Neurocognitive Benefits of Second-Generation Antipsychotics Versus Placebo: Insufficient Evidence Based on a Systematic Review

被引：9
作者：
Takeuchi, Hiroyoshi [1 ,2 ,3 ]
Thiyanavadivel, Sadhana [1 ,4 ]
Fervaha, Gagan [1 ,5 ]
Remington, Gary [1 ,2 ,5 ,6 ]
机构：
[1] Univ Toronto, Schizophrenia Div, Complex Care & Recovery Program, Ctr Addict & Mental Hlth, Toronto, ON, Canada
[2] Univ Toronto, Dept Psychiat, Toronto, ON, Canada
[3] Keio Univ, Sch Med, Dept Neuropsychiat, Tokyo, Japan
[4] Univ Toronto, Dept Anthropol, Toronto, ON, Canada
[5] Univ Toronto, Inst Med Sci, Toronto, ON, Canada
[6] Ctr Addict & Mental Hlth, Campbell Family Mental Hlth Res Inst, Toronto, ON, Canada
来源：
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY | 2017年 / 37卷 / 02期
基金：
加拿大健康研究院;
关键词：
1ST-EPISODE SCHIZOPHRENIA; METAANALYSIS; OLANZAPINE; COGNITION; RISPERIDONE;
D O I：
10.1097/JCP.0000000000000662
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：274 / 276
页数：3
相关论文
共 12 条
[1]   Changes in Neurocognitive Function in Patients With Schizophrenia After Starting or Switching to Amisulpride in Comparison With the Normal Controls [J].
Ahn, Yong Min ;
Lee, Kyu Young ;
Kim, Chul-Eung ;
Kim, Jae-Jin ;
Kang, Dae-Yeob ;
Jun, Tae-Youn ;
Choi, Jin Sook ;
Chung, In-Won ;
Kim, Se Hyun ;
Hwang, Samuel S. -H. ;
Kim, Yong Sik .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2009, 29 (02) :117-123
[2]   Neurocognitive Effectiveness of Haloperidol, Risperidone, and Olanzapine in First-Episode Psychosis: A Randomized, Controlled 1-Year Follow-Up Comparison [J].
Crespo-Facorro, Benedicto ;
Rodriguez-Sanchez, Jose M. ;
Perez-Iglesias, Rocio ;
Mata, Ignacio ;
Ayesa, Rosa ;
Ramirez-Bonilla, MariLuz ;
Martinez-Garcia, Obdulia ;
Vasquez-Barquero, Jose L. .
JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (05) :717-729
[3]   Long-term neurocognitive effects of antipsychotics in schizophrenia: a network meta-analysis [J].
Desamericq, G. ;
Schurhoff, F. ;
Meary, A. ;
Szoeke, A. ;
Macquin-Mavier, I. ;
Bachoud-Levi, A. C. ;
Maison, P. .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 70 (02) :127-134
[4]  
Geffen Yona, 2012, J Clin Psychiatry, V73, pe1168, DOI 10.4088/JCP.12m07642
[5]   Cognitive improvement after treatment with second-generation antipsychotic medications in first-episode schizophrenia - Is it a practice effect? [J].
Goldberg, Terry E. ;
Goldman, Robert S. ;
Burdick, Katherine E. ;
Malhotra, Anil K. ;
Lencz, Todd ;
Patel, Raman C. ;
Woerner, Margaret G. ;
Schooler, Nina R. ;
Kane, John M. ;
Robinson, Delbert G. .
ARCHIVES OF GENERAL PSYCHIATRY, 2007, 64 (10) :1115-1122
[6]   Circumstances Under Which Practice Does Not Make Perfect: A Review of the Practice Effect Literature in Schizophrenia and Its Relevance to Clinical Treatment Studies [J].
Goldberg, Terry E. ;
Keefe, Richard S. E. ;
Goldman, Robert S. ;
Robinson, Delbert G. ;
Harvey, Philip D. .
NEUROPSYCHOPHARMACOLOGY, 2010, 35 (05) :1053-1062
[7]   Effect of lurasidone on neurocognitive performance in patients with schizophrenia: A short-term placebo- and active-controlled study followed by a 6-month double-blind extension [J].
Harvey, Philip D. ;
Siu, Cynthia O. ;
Hsu, Jay ;
Cucchiaro, Josephine ;
Maruff, Paul ;
Loebel, Antony .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (11) :1373-1382
[8]   The Selective Neurokinin 3 Antagonist AZD2624 Does Not Improve Symptoms or Cognition in Schizophrenia A Proof-of-Principle Study [J].
Litman, Robert E. ;
Smith, Mark A. ;
Desai, Dhaval G. ;
Simpson, Thomas ;
Sweitzer, Dennis ;
Kanes, Stephen J. .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2014, 34 (02) :199-204
[9]   A meta-analysis and critical review of the effects of conventional neuroleptic treatment on cognition in schizophrenia: Opening a closed book [J].
Mishara, AL ;
Goldberg, TE .
BIOLOGICAL PSYCHIATRY, 2004, 55 (10) :1013-1022
[10]   Second-generation antipsychotic effect on cognition in patients with schizophrenia-a meta-analysis of randomized clinical trials [J].
Nielsen, R. E. ;
Levander, S. ;
Kjaersdam Telleus, G. ;
Jensen, S. O. W. ;
Ostergaard Christensen, T. ;
Leucht, S. .
ACTA PSYCHIATRICA SCANDINAVICA, 2015, 131 (03) :185-196
12